Trade Vericel Corp Ord - VCEL CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.16 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 51.65 |
| Open | 51.36 |
| 1-Year Change | 37.69% |
| Day's Range | 51.3 - 52.43 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 51.60 | -0.97 | -1.85% | 52.57 | 53.98 | 51.45 |
| Jul 24, 2024 | 52.33 | 0.38 | 0.73% | 51.95 | 53.74 | 51.95 |
| Jul 23, 2024 | 52.74 | 1.79 | 3.51% | 50.95 | 53.31 | 50.95 |
| Jul 22, 2024 | 51.47 | 1.61 | 3.23% | 49.86 | 51.74 | 49.01 |
| Jul 19, 2024 | 49.98 | -1.23 | -2.40% | 51.21 | 51.49 | 49.20 |
| Jul 18, 2024 | 51.14 | 0.93 | 1.85% | 50.21 | 52.20 | 50.21 |
| Jul 17, 2024 | 51.68 | 0.59 | 1.15% | 51.09 | 52.85 | 50.69 |
| Jul 16, 2024 | 52.14 | 3.58 | 7.37% | 48.56 | 52.60 | 48.56 |
| Jul 15, 2024 | 49.79 | 1.32 | 2.72% | 48.47 | 50.14 | 47.87 |
| Jul 12, 2024 | 48.44 | -0.94 | -1.90% | 49.38 | 50.22 | 48.02 |
| Jul 11, 2024 | 49.35 | 3.92 | 8.63% | 45.43 | 49.62 | 45.43 |
| Jul 10, 2024 | 45.35 | -0.68 | -1.48% | 46.03 | 46.39 | 44.53 |
| Jul 9, 2024 | 45.97 | -0.62 | -1.33% | 46.59 | 46.95 | 45.15 |
| Jul 8, 2024 | 46.83 | -0.36 | -0.76% | 47.19 | 47.93 | 46.04 |
| Jul 5, 2024 | 46.60 | 1.71 | 3.81% | 44.89 | 46.79 | 43.96 |
| Jul 3, 2024 | 44.82 | 0.00 | 0.00% | 44.82 | 45.11 | 43.96 |
| Jul 2, 2024 | 45.02 | 1.05 | 2.39% | 43.97 | 45.39 | 43.96 |
| Jul 1, 2024 | 44.99 | 0.03 | 0.07% | 44.96 | 45.86 | 44.40 |
| Jun 28, 2024 | 45.75 | -1.20 | -2.56% | 46.95 | 47.09 | 45.14 |
| Jun 27, 2024 | 46.86 | 0.90 | 1.96% | 45.96 | 47.92 | 45.76 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Vericel Corp Ord Company profile
About Vericel Corp
Vericel Corporation is a commercial-stage biopharmaceutical company. The Company specializes in cell therapies and specialty biologics for the sports medicine and severe burn care. It operates in one reportable segment, the research, product development, manufacture, and distribution of cellular therapies for use in the treatment of specific diseases. It markets two autologous cell therapy products in the United States, which includes MACI (autologous cultured chondrocytes on porcine collagen membrane) and Epicel (cultured epidermal autografts). The MACI is an autologous cellularized scaffold product indicated for the repair of symptomatic, single, or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. The Epicel is a permanent skin replacement humanitarian use device (HUD) for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns comprising greater than or equal to 30% of total body surface area (TBSA).
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Vericel Corp revenues increased 26% to $156.2M. Net loss totaled $7.5M vs. income of $2.9M. Revenues reflect MACI segment increase of 18% to $111.6M, Epicel segment increase of 51% to $41.5M. Net loss reflects Stock-based Compensation in SGA increase from $10M to $26.5M (expense), Other Selling , General Expense increase of 21% to $71.1M (expense).
Equity composition
Common Stock no Par, 3/11, 62.5M auth., 38,618,037 issd. Insiders control approx. 0.63%. IPO: 2/97, 3M shares @ $7 byCowen & Company. 02/10 1-for-8 reverse split. 10/13, 1-for-20 Reverse Stock split.
| Industry: | Biopharmaceuticals |
64 Sidney St
CAMBRIDGE
MASSACHUSETTS 02139-4170
US
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com